ONWARD MEDICAL (ONWD.BR) Fundamental Analysis & Valuation
EBR:ONWD • NL0015000HT4
Current stock price
3.235 EUR
-0.18 (-5.27%)
Last:
This ONWD.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ONWD.BR Profitability Analysis
1.1 Basic Checks
- ONWD had negative earnings in the past year.
- In the past year ONWD has reported a negative cash flow from operations.
- In the past 5 years ONWD always reported negative net income.
- In the past 5 years ONWD always reported negative operating cash flow.
1.2 Ratios
- ONWD has a worse Return On Assets (-67.68%) than 88.52% of its industry peers.
- With a Return On Equity value of -137.73%, ONWD is not doing good in the industry: 81.97% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -67.68% | ||
| ROE | -137.73% | ||
| ROIC | N/A |
ROA(3y)-57.55%
ROA(5y)-69.28%
ROE(3y)-112.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- ONWD's Gross Margin of 77.16% is amongst the best of the industry. ONWD outperforms 88.52% of its industry peers.
- The Profit Margin and Operating Margin are not available for ONWD so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 77.16% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. ONWD.BR Health Analysis
2.1 Basic Checks
- ONWD does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, ONWD has more shares outstanding
- Compared to 5 years ago, ONWD has more shares outstanding
- Compared to 1 year ago, ONWD has an improved debt to assets ratio.
2.2 Solvency
- ONWD has an Altman-Z score of -2.39. This is a bad value and indicates that ONWD is not financially healthy and even has some risk of bankruptcy.
- ONWD has a worse Altman-Z score (-2.39) than 81.97% of its industry peers.
- ONWD has a Debt/Equity ratio of 0.52. This is a neutral value indicating ONWD is somewhat dependend on debt financing.
- ONWD's Debt to Equity ratio of 0.52 is on the low side compared to the rest of the industry. ONWD is outperformed by 60.66% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -2.39 |
ROIC/WACCN/A
WACC7.49%
2.3 Liquidity
- ONWD has a Current Ratio of 4.34. This indicates that ONWD is financially healthy and has no problem in meeting its short term obligations.
- The Current ratio of ONWD (4.34) is better than 93.44% of its industry peers.
- A Quick Ratio of 4.30 indicates that ONWD has no problem at all paying its short term obligations.
- ONWD has a Quick ratio of 4.30. This is amongst the best in the industry. ONWD outperforms 98.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.34 | ||
| Quick Ratio | 4.3 |
3. ONWD.BR Growth Analysis
3.1 Past
- ONWD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.69%, which is quite impressive.
- The Revenue has grown by 236.76% in the past year. This is a very strong growth!
EPS 1Y (TTM)20.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.47%
Revenue 1Y (TTM)236.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- The Earnings Per Share is expected to grow by 12.03% on average over the next years. This is quite good.
- Based on estimates for the next years, ONWD will show a very strong growth in Revenue. The Revenue will grow by 148.02% on average per year.
EPS Next Y8.5%
EPS Next 2Y5.76%
EPS Next 3Y12.03%
EPS Next 5YN/A
Revenue Next Year313%
Revenue Next 2Y226.6%
Revenue Next 3Y218.91%
Revenue Next 5Y148.02%
3.3 Evolution
4. ONWD.BR Valuation Analysis
4.1 Price/Earnings Ratio
- ONWD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year ONWD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- ONWD's earnings are expected to grow with 12.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.76%
EPS Next 3Y12.03%
5. ONWD.BR Dividend Analysis
5.1 Amount
- No dividends for ONWD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ONWD.BR Fundamentals: All Metrics, Ratios and Statistics
EBR:ONWD (4/2/2026, 7:00:00 PM)
3.235
-0.18 (-5.27%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-24 2025-11-24
Earnings (Next)04-29 2026-04-29/amc
Inst Owners27.61%
Inst Owner ChangeN/A
Ins Owners9.81%
Ins Owner ChangeN/A
Market Cap181.19M
Revenue(TTM)1.11M
Net Income(TTM)-38.18M
Analysts87.27
Price Target10.42 (222.1%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-5.15%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-9.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 162.94 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 6.54 | ||
| P/tB | 9.81 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.86
EYN/A
EPS(NY)-0.8
Fwd EYN/A
FCF(TTM)-0.64
FCFYN/A
OCF(TTM)-0.64
OCFYN/A
SpS0.02
BVpS0.49
TBVpS0.33
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -67.68% | ||
| ROE | -137.73% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 77.16% | ||
| FCFM | N/A |
ROA(3y)-57.55%
ROA(5y)-69.28%
ROE(3y)-112.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.02
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 37.34% | ||
| Cap/Sales | 31.3% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 4.34 | ||
| Quick Ratio | 4.3 | ||
| Altman-Z | -2.39 |
F-Score6
WACC7.49%
ROIC/WACCN/A
Cap/Depr(3y)43.86%
Cap/Depr(5y)180.36%
Cap/Sales(3y)362.35%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.47%
EPS Next Y8.5%
EPS Next 2Y5.76%
EPS Next 3Y12.03%
EPS Next 5YN/A
Revenue 1Y (TTM)236.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year313%
Revenue Next 2Y226.6%
Revenue Next 3Y218.91%
Revenue Next 5Y148.02%
EBIT growth 1Y0.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-22.55%
EBIT Next 3Y4.97%
EBIT Next 5YN/A
FCF growth 1Y-9.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.94%
OCF growth 3YN/A
OCF growth 5YN/A
ONWARD MEDICAL / ONWD.BR Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for ONWARD MEDICAL?
ChartMill assigns a fundamental rating of 2 / 10 to ONWD.BR.
What is the valuation status of ONWARD MEDICAL (ONWD.BR) stock?
ChartMill assigns a valuation rating of 0 / 10 to ONWARD MEDICAL (ONWD.BR). This can be considered as Overvalued.
How profitable is ONWARD MEDICAL (ONWD.BR) stock?
ONWARD MEDICAL (ONWD.BR) has a profitability rating of 1 / 10.
What is the expected EPS growth for ONWARD MEDICAL (ONWD.BR) stock?
The Earnings per Share (EPS) of ONWARD MEDICAL (ONWD.BR) is expected to grow by 8.5% in the next year.